Advertisement

Topics

Search Results for "Dabur Sanat Pharma"

18:37 EDT 26th May 2017 | BioPortfolio

Matching Channels

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

Eligard

Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Zyme Communications

Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value, and generate interest from commercial leads...

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Matching News

VERONA PHARMA PLC - Issue of Equity

PR NewswireLondon, December 29 Verona Pharma plc ("Verona Pharma" or the "Company") Exercise of Options Verona Pharma plc (AIM: VRP), the drug development company focused on first-in-class medicin...

NASDAQ OMX Nordic: Derivatives: Anticipated adjustment in Karo Pharma due to rights issue (02/17)

The following information is based on a press release from Karo Pharma AB (Karo Pharma) published on January 16, 2017 and may be subject to change. The board of Karo Pharma has proposed that the Ex...

NASDAQ OMX Nordic: Derivatives: Anticipated adjustment due to extraordinary dividend in Karo Pharma (14/17)

The following information is based on a press release from Karo Pharma AB (Karo Pharma) published April 10, 2017 and may be subject to change. The board of Karo Pharma has proposed that the Annual ...

NASDAQ OMX Nordic: Derivatives: Anticipated adjustment due to extraordinary dividend in Karo Pharma (13/17)

The following information is based on a press release from Karo Pharma AB (Karo Pharma) published March 31, 2017 and may be subject to change. The board of Karo Pharma has proposed that the Annual ...

Tetra Bio-Pharma Inc. Announces a New Appointment to its Scientific and Clinical Advisory Board

OTTAWA, ONTARIO -- (Marketwired) -- 01/11/17 -- PhytoPain Pharma Inc. ("PhytoPain Pharma" or "PPP"), a subsidiary of Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE: TBP)(CSE: TBP.CN)(OTC PI...

Mezzion hires Pol Pharma and Halo Pharma and accuses Dr Reddy's of fraud

Mezzion has hired Pol Pharma and Halo Pharma and accused former CMO Dr Reddy’s of hiding manufacturing problems that cost its erectile dysfunction candidate, udenafil, US approval.

Top 32 Pharma companies: Perception of Pharma Companies Pairing of the Most Admired Pharma Companies – A Survey by eyeforpharma, its mission is to make Pharma companies more open and valued

Top 32 Pharma companies: Perception of Pharma Companies Pairing of the Most Admired Pharma Companies – A Survey by eyeforpharma, its mission is to make Pharma companies more open and valued R...

Verona Pharma plc: Verona Pharma to Present at Jefferies 2017 Global Healthcare Conference

May 23, 2017, LONDON - Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics for...

Matching PubMed Articles

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement